Lexicon Pharmaceuticals LXRX

Lexicon Pharmaceuticals , Inc. ( LXRX ) Q1 2012 Earnings Conference Call May 3, 2012 11:00 ET ..... Morgan Stanley Presentation Operator Welcome to the Lexicon Pharmaceuticals ' First Quarter 2012 Conference Call. At this time …

By Scott Matusow : Yesterday after the Bell, Protalix ( PLX ) received approval from the FDA for its drug Elelyso, (taliglucerase alfa) which is a proprietary plant cell expressed recombinant Glucocerebrosidase enzyme for the treatment of a rare genetic disorder called Gaucher disease. Gaucher ...

By Ganaxi Small Cap Movers : The biotech group as represented by the NYSE ARCA Biotech Index ($BTK) has been strong this year, now up over 27% YTD, and still trending higher. With both the market and the biotech sector in strong bull mode, now maybe an opportune time to go 'shop' for biotech ...

By Kapitall : The biotech industry is considered a growth industry with a very unique set of risks, mainly concerning the ability for research to turn into commercial success. For ideas on how to analyze stocks in the industry, we ran a screen. We screened the biotech industry for stocks seeing ...

By Kapitall : Comparing a stock's trading trends to its changes in number of shares shorted can lead to some interesting results. We ran a screen on the biotech industry for stocks rallying above their 20-day, 50-day, and 200-day moving averages. We then screened these stocks for those with ...

By Kapitall : Interested in momentum trading strategies? Here are some ideas to get you started on your search. The concept of "technical momentum" implies that upside momentum may persist as more investors hear and agree with the market's positive sentiment about a stock. In the search for ...

By Stephen Simpson : Shares of small biotech Lexicon Pharmaceuticals ( LXRX ) sold off sharply in the wake of news that the FDA issued it's much-expected rejection letter to Bristol-Myers Squibb …